Fulcrum Therapeutics (FULC) News Today $8.95 -0.09 (-1.00%) Closing price 04:00 PM EasternExtended Trading$8.90 -0.05 (-0.56%) As of 06:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FULC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period What is Leerink Partnrs' Forecast for FULC FY2027 Earnings?October 23 at 8:02 AM | marketbeat.comFulcrum Therapeutics to Release Q3 2025 Financial Results on October 29, 2025October 22 at 9:11 AM | quiverquant.comQFulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ETOctober 22 at 9:03 AM | globenewswire.comHC Wainwright Reiterates "Buy" Rating for Fulcrum Therapeutics (NASDAQ:FULC)October 22 at 2:43 AM | americanbankingnews.comHC Wainwright & Co. Reiterates Fulcrum Therapeutics (FULC) Buy RecommendationOctober 21 at 8:26 AM | msn.comHC Wainwright Reaffirms "Buy" Rating for Fulcrum Therapeutics (NASDAQ:FULC)October 20 at 8:16 AM | marketbeat.comAberdeen Group plc Takes Position in Fulcrum Therapeutics, Inc. $FULCOctober 19, 2025 | marketbeat.comFulcrum Therapeutics (NASDAQ:FULC) Trading 8.7% Higher - Should You Buy?October 16, 2025 | marketbeat.comFulcrum Therapeutics (NASDAQ:FULC) Hits New 12-Month High - Here's WhyOctober 16, 2025 | marketbeat.comBrokerages Set Fulcrum Therapeutics, Inc. (NASDAQ:FULC) PT at $9.60October 16, 2025 | americanbankingnews.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Rating of "Moderate Buy" by BrokeragesOctober 16, 2025 | americanbankingnews.comFulcrum Therapeutics to Present Preclinical Data for EED Inhibitor FTX-6274 at European Society for Medical Oncology (ESMO) Congress 2025October 14, 2025 | markets.businessinsider.comFulcrum Therapeutics Presents Preclinical Data for FTX-6274 as a Potential Treatment for Castration-Resistant Prostate CancerOctober 14, 2025 | quiverquant.comQLeerink Partners Reaffirms Their Buy Rating on Fulcrum Therapeutics (FULC)October 12, 2025 | theglobeandmail.comWhat is Leerink Partnrs' Estimate for FULC FY2027 Earnings?October 11, 2025 | marketbeat.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Rating of "Moderate Buy" from BrokeragesOctober 11, 2025 | marketbeat.comFulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 10, 2025 | globenewswire.comFulcrum Therapeutics (NASDAQ:FULC) Given Sell (D-) Rating at Weiss RatingsOctober 9, 2025 | marketbeat.comFulcrum Therapeutics (NASDAQ:FULC) Reaches New 12-Month High - Here's What HappenedOctober 8, 2025 | marketbeat.comFulcrum Therapeutics, Inc. $FULC Shares Sold by Matisse CapitalOctober 8, 2025 | marketbeat.comCantor Fitzgerald Sticks to Their Buy Rating for Fulcrum Therapeutics (FULC)October 7, 2025 | theglobeandmail.comOppenheimer Remains a Buy on Fulcrum Therapeutics (FULC)October 3, 2025 | theglobeandmail.comFulcrum Therapeutics (NASDAQ:FULC) Sets New 52-Week High - Time to Buy?October 1, 2025 | marketbeat.comFulcrum Therapeutics (NASDAQ:FULC) Raised to Hold at Wall Street ZenSeptember 26, 2025 | marketbeat.comStrs Ohio Makes New Investment in Fulcrum Therapeutics, Inc. $FULCSeptember 25, 2025 | marketbeat.comGoldman Sachs Group Inc. Reduces Holdings in Fulcrum Therapeutics, Inc. $FULCSeptember 22, 2025 | marketbeat.comAcadian Asset Management LLC Increases Stock Position in Fulcrum Therapeutics, Inc. $FULCSeptember 18, 2025 | marketbeat.comHere's Why We're Not Too Worried About Fulcrum Therapeutics' (NASDAQ:FULC) Cash Burn SituationSeptember 17, 2025 | finance.yahoo.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Rating of "Buy" from BrokeragesSeptember 17, 2025 | marketbeat.comShort Interest in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Decreases By 36.1%September 16, 2025 | marketbeat.com147,654 Shares in Fulcrum Therapeutics, Inc. $FULC Acquired by Jacobs Levy Equity Management Inc.September 15, 2025 | marketbeat.comFulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 12, 2025 | globenewswire.comExome Asset Management LLC Purchases 405,538 Shares of Fulcrum Therapeutics, Inc. $FULCSeptember 11, 2025 | marketbeat.comInvesco Ltd. Raises Stake in Fulcrum Therapeutics, Inc. $FULCSeptember 9, 2025 | marketbeat.comNuveen LLC Makes New $441,000 Investment in Fulcrum Therapeutics, Inc. $FULCSeptember 7, 2025 | marketbeat.comADAR1 Capital Management LLC Raises Stake in Fulcrum Therapeutics, Inc. $FULCSeptember 4, 2025 | marketbeat.comFulcrum Therapeutics, Inc. $FULC Shares Bought by Nantahala Capital Management LLCSeptember 3, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Lowers Position in Fulcrum Therapeutics, Inc. $FULCSeptember 3, 2025 | marketbeat.comMaxion Therapeutics Strengthens Board with Appointment of Dr. Santiago Arroyo as a Non-Executive DirectorAugust 27, 2025 | markets.businessinsider.comFulcrum Therapeutics to Present at Upcoming Investor Conferences in September 2025August 26, 2025 | quiverquant.comQFulcrum Therapeutics to Present at Upcoming Investor MeetingsAugust 26, 2025 | globenewswire.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Average Recommendation of "Moderate Buy" from BrokeragesAugust 24, 2025 | marketbeat.comFulcrum Therapeutics, Inc. $FULC Shares Sold by Connor Clark & Lunn Investment Management Ltd.August 20, 2025 | marketbeat.comXTX Topco Ltd Takes Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC)August 15, 2025 | marketbeat.comFulcrum Therapeutics (NASDAQ:FULC) Stock Rating Lowered by Wall Street ZenAugust 10, 2025 | marketbeat.comFulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 8, 2025 | globenewswire.comAIRNA Appoints Tamara Joseph as Chief Legal Officer and Kristina Storey as Head of Regulatory AffairsAugust 6, 2025 | finance.yahoo.comFULC Fulcrum Therapeutics, Inc. - Seeking AlphaAugust 5, 2025 | seekingalpha.comFY2025 EPS Estimates for FULC Raised by Cantor FitzgeraldAugust 2, 2025 | marketbeat.comHC Wainwright Issues Optimistic Outlook for FULC EarningsAugust 2, 2025 | marketbeat.com Get Fulcrum Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FULC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FULC Media Mentions By Week FULC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FULC News Sentiment▼0.500.52▲Average Medical News Sentiment FULC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FULC Articles This Week▼93▲FULC Articles Average Week Get the Latest News and Ratings for FULC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Fulcrum Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies COGT News Today STOK News Today VCEL News Today RCUS News Today TLRY News Today TWST News Today IMCR News Today BHVN News Today ABCL News Today PAHC News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FULC) was last updated on 10/23/2025 by MarketBeat.com Staff From Our PartnersRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulcrum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulcrum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FULC Stock Alerts